Yugeng Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yugeng Liu has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Beile Gao
State Key Laboratory of Tropical Oceanography, Guangdong Provincial Key Laboratory of Applied Marine Biology, Innovation Academy of South China Sea Ecology and Environmental Engineering, Guangdong Provincial Observation and Research Station for Coastal Upwelling Ecosystem, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou, China
1 shared publication - Bin Jiang
Shenzhen Branch, Guangdong Laboratory for Lingnan Modern Agriculture, Key Laboratory of Synthetic Biology, Ministry of Agriculture and Rural Affairs, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences, Shenzhen, China
1 shared publication - Daoxin Xie
Tsinghua-Peking Joint Center for Life Sciences, and School of Life Sciences, Tsinghua University, Beijing 100084, China
1 shared publication Gang Yao
The People's Hospital of Zhengyang County Zhumadian Henan China
1 shared publication- Haijun Wang
Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing, China
1 shared publication Han Ke
Beijing National Laboratory for Molecular Sciences, Peking-Tsinghua Center for Life Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing, China
1 shared publication
Latest Publications
- Top Cited Papers
- 9 February 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 383 (6683) , 622-629
Characterization and heterologous reconstitution of Taxus biosynthetic enzymes leading to baccatin III
Paclitaxel is a well known anticancer compound. Its biosynthesis involves the formation of a highly functionalized diterpenoid core skeleton (baccatin III) and the subsequent assembly of a phenylisoserinoyl side chain. Despite intensive investigation for half a century, the complete biosynthetic pathway of baccatin III remains unknown. In this work, we identified a bifunctional cytochrome P450 enzyme [taxane oxetanase 1 (TOT1)] in Taxus mairei that catalyzes an oxidative rearrangement in paclitaxel oxetane formation, which represents a previously unknown enzyme mechanism for oxetane ring formation. We created a screening strategy based on the taxusin biosynthesis pathway and uncovered the enzyme responsible for the taxane oxidation of the C9 position (T9αH1). Finally, we artificially reconstituted a biosynthetic pathway for the production of baccatin III in tobacco.
- 9 February 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 383 (6683) , 622-629
Top Cited PapersCharacterization and heterologous reconstitution of Taxus biosynthetic enzymes leading to baccatin III
Paclitaxel is a well known anticancer compound. Its biosynthesis involves the formation of a highly functionalized diterpenoid core skeleton (baccatin III) and the subsequent assembly of a phenylisoserinoyl side chain. Despite intensive investigation for half a century, the complete biosynthetic pathway of baccatin III remains unknown. In this work, we identified a bifunctional cytochrome P450 enzyme [taxane oxetanase 1 (TOT1)] in Taxus mairei that catalyzes an oxidative rearrangement in paclitaxel oxetane formation, which represents a previously unknown enzyme mechanism for oxetane ring formation. We created a screening strategy based on the taxusin biosynthesis pathway and uncovered the enzyme responsible for the taxane oxidation of the C9 position (T9αH1). Finally, we artificially reconstituted a biosynthetic pathway for the production of baccatin III in tobacco.
- Open Access
- 11 January 2023
- Published by Wiley in Clinical and Translational Medicine
- Vol. 13 (1) , e1164
c‐Myc–IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming
Background: Metabolic reprogramming is a hallmark of cancer. Metabolic rate‐limiting enzymes and oncogenic c‐Myc (Myc) play critical roles in metabolic reprogramming to affect tumourigenesis. However, a systematic assessment of metabolic rate‐limiting enzymes and their relationship with Myc in human cancers is lacking.Methods: Multiple Pan‐cancer datasets were used to develop the transcriptome, genomic alterations, clinical outcomes and Myc correlation landscapes of 168 metabolic rate‐limiting enzymes across 20 cancers. Real‐time quantitative PCR and immunoblotting were, respectively, used to examine the mRNA and protein of inosine monophosphate dehydrogenase 1 (IMPDH1) in human colorectal cancer (CRC), azoxymethane/dextran sulphate sodium‐induced mouse CRC and spontaneous intestinal tumours from APCMin/+ mice. Clone formation, CCK‐8 and subcutaneous xenograft model were applied to investigate the possible mechanisms connecting IMPDH1 to CRC growth. Co‐immunoprecipitation and protein half‐life assay were used to explore the mechanisms underlying the regulation of IMPDH1.Results: We explored the global expression patterns, dysregulation profiles, genomic alterations and clinical relevance of 168 metabolic rate‐limiting enzymes across human cancers. Importantly, a series of enzymes were associated with Myc, especially top three upregulated enzymes (TK1, RRM2 and IMPDH1) were positively correlated with Myc in multiple cancers. As a proof‐of‐concept exemplification, we demonstrated that IMPDH1, a rate‐limiting enzyme in GTP biosynthesis, is highly upregulated in CRC and promotes CRC growth in vitro and in vivo. Mechanistically, IMPDH2 stabilizes IMPDH1 by decreasing the polyubiquitination levels of IMPDH1, and Myc promotes the de novo GTP biosynthesis by the transcriptional activation of IMPDH1/2. Finally, we confirmed that the Myc–IMPDH1/2 axis is dysregulated across human cancers.Conclusions: Our study highlights the essential roles of metabolic rate‐limiting enzymes in tumourigenesis and their crosstalk with Myc, and the Myc–IMPDH1/2 axis promotes tumourigenesis by altering GTP metabolic reprogramming. Our results propose the inhibition of IMPDH1 as a viable option for cancer treatment.
- 11 January 2023
- Published by Wiley in Clinical and Translational Medicine
- Vol. 13 (1) , e1164
Open Accessc‐Myc–IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming
Background: Metabolic reprogramming is a hallmark of cancer. Metabolic rate‐limiting enzymes and oncogenic c‐Myc (Myc) play critical roles in metabolic reprogramming to affect tumourigenesis. However, a systematic assessment of metabolic rate‐limiting enzymes and their relationship with Myc in human cancers is lacking.Methods: Multiple Pan‐cancer datasets were used to develop the transcriptome, genomic alterations, clinical outcomes and Myc correlation landscapes of 168 metabolic rate‐limiting enzymes across 20 cancers. Real‐time quantitative PCR and immunoblotting were, respectively, used to examine the mRNA and protein of inosine monophosphate dehydrogenase 1 (IMPDH1) in human colorectal cancer (CRC), azoxymethane/dextran sulphate sodium‐induced mouse CRC and spontaneous intestinal tumours from APCMin/+ mice. Clone formation, CCK‐8 and subcutaneous xenograft model were applied to investigate the possible mechanisms connecting IMPDH1 to CRC growth. Co‐immunoprecipitation and protein half‐life assay were used to explore the mechanisms underlying the regulation of IMPDH1.Results: We explored the global expression patterns, dysregulation profiles, genomic alterations and clinical relevance of 168 metabolic rate‐limiting enzymes across human cancers. Importantly, a series of enzymes were associated with Myc, especially top three upregulated enzymes (TK1, RRM2 and IMPDH1) were positively correlated with Myc in multiple cancers. As a proof‐of‐concept exemplification, we demonstrated that IMPDH1, a rate‐limiting enzyme in GTP biosynthesis, is highly upregulated in CRC and promotes CRC growth in vitro and in vivo. Mechanistically, IMPDH2 stabilizes IMPDH1 by decreasing the polyubiquitination levels of IMPDH1, and Myc promotes the de novo GTP biosynthesis by the transcriptional activation of IMPDH1/2. Finally, we confirmed that the Myc–IMPDH1/2 axis is dysregulated across human cancers.Conclusions: Our study highlights the essential roles of metabolic rate‐limiting enzymes in tumourigenesis and their crosstalk with Myc, and the Myc–IMPDH1/2 axis promotes tumourigenesis by altering GTP metabolic reprogramming. Our results propose the inhibition of IMPDH1 as a viable option for cancer treatment.
- Open Access
- 14 July 2022
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 18 (7) , e1010316
The evolutionary path of chemosensory and flagellar macromolecular machines in Campylobacterota
The evolution of macromolecular complex is a fundamental biological question, which is related to the origin of life and also guides our practice in synthetic biology. The chemosensory system is one of the complex structures that evolved very early in bacteria and displays enormous diversity and complexity in terms of composition and array structure in modern species. However, how the diversity and complexity of the chemosensory system evolved remains unclear. Here, using the Campylobacterota phylum with a robust “eco-evo” framework, we investigated the co-evolution of the chemosensory system and one of its important signaling outputs, flagellar machinery. Our analyses show that substantial flagellar gene alterations will lead to switch of its primary chemosensory class from one to another, or result in a hybrid of two classes. Unexpectedly, we discovered that the high-torque generating flagellar motor structure of Campylobacter jejuni and Helicobacter pylori likely evolved in the last common ancestor of the Campylobacterota phylum. Later lineages that experienced significant flagellar alterations lost some key components of complex scaffolding structures, thus derived simpler structures than their ancestor. Overall, this study revealed the co-evolutionary path of the chemosensory system and flagellar system, and highlights that the evolution of flagellar structural complexity requires more investigation in the Bacteria domain based on a resolved phylogenetic framework, with no assumptions on the evolutionary direction.
- 14 July 2022
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 18 (7) , e1010316
Open AccessThe evolutionary path of chemosensory and flagellar macromolecular machines in Campylobacterota
The evolution of macromolecular complex is a fundamental biological question, which is related to the origin of life and also guides our practice in synthetic biology. The chemosensory system is one of the complex structures that evolved very early in bacteria and displays enormous diversity and complexity in terms of composition and array structure in modern species. However, how the diversity and complexity of the chemosensory system evolved remains unclear. Here, using the Campylobacterota phylum with a robust “eco-evo” framework, we investigated the co-evolution of the chemosensory system and one of its important signaling outputs, flagellar machinery. Our analyses show that substantial flagellar gene alterations will lead to switch of its primary chemosensory class from one to another, or result in a hybrid of two classes. Unexpectedly, we discovered that the high-torque generating flagellar motor structure of Campylobacter jejuni and Helicobacter pylori likely evolved in the last common ancestor of the Campylobacterota phylum. Later lineages that experienced significant flagellar alterations lost some key components of complex scaffolding structures, thus derived simpler structures than their ancestor. Overall, this study revealed the co-evolutionary path of the chemosensory system and flagellar system, and highlights that the evolution of flagellar structural complexity requires more investigation in the Bacteria domain based on a resolved phylogenetic framework, with no assumptions on the evolutionary direction.